Figure 1 Supplement - Prisma with reasons - with references

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097

For more information, visit www.prisma-statement.org.

Supplement: Figure 1: PRISMA Flow Diagram with references

Records identified through database searching

(n =23589 )

Scre

enin

g In

clud

ed

Elig

ibili

ty

Iden

tific

atio

n

Additional records identified through other sources

(n =12 )

Records after duplicates removed (n =19500 )

Records screened (n =19500 )

Records excluded (n =19181 )

Full-text articles assessed for eligibility

(n =319)

Full-text articles excluded, (n =232)

No RoB/quality rating: 1-15 No TAU/Placebo: 16-39

Mixing TAU with other comparators:5, 40-68 Subgroups/specific

setting: 15, 18, 19, 26, 51, 56, 69-125 Other reasons (e.g.

augmentation, secondary outcomes, no effect sizes):

4, 80, 117, 126-232

Studies included (May 2020)

(n = 87 )

Update March 2021 Studies included

(n = 102)



1 Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D. Efficacy of treatments for anxiety disorders: a meta-analysis International Clinical Psychopharmacology 2015; 30(4): 183-192 2 Biesheuvel-Leliefeld KE, Kok GD, Bockting CL, Cuijpers P, Hollon SD, Van Marwijk HW, Smit F. Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression Journal of affective disorders 2015; 174: 400-410 3 Blodgett JC, Del Re A, Maisel NC, Finney JW. A meta‐analysis of topiramate's effects for individuals with alcohol use disorders Alcoholism: Clinical and Experimental Research 2014; 38(6): 1481-1488 4 De Crescenzo F, Cortese S, Adamo N, Janiri L. Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review Evidence-Based Mental Health 2017; 20(1): 4-11 5 Eichner C, Berna F. Acceptance and Efficacy of Metacognitive Training (MCT) on Positive Symptoms and Delusions in Patients With Schizophrenia: A Meta-analysis Taking Into Account Important Moderators Schizophrenia bulletin 2016; 42(4): 952–962 [PMCID: 26748396 Journal Article Meta-Analysis DOI: 10.1093/schbul/sbv225] 6 Generoso MB, Trevizol AP, Kasper S, Cho HJ, Cordeiro Q, Shiozawa P. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis International clinical psychopharmacology 2017; 32(1): 49–55 [PMCID: 27643884 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1097/yic.0000000000000147] 7 Gu W, Wang C, Li Z, Wang Z, Zhang X. Pharmacotherapies for Posttraumatic Stress Disorder: A Meta-Analysis The Journal of nervous and mental disease 2016; 204(5): 331–338 [PMCID: 26894318 Journal Article Meta-Analysis DOI: 10.1097/nmd.0000000000000478] 8 Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders Depression and anxiety 2019; 36(3): 198–212 [PMCID: 30479005 Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1002/da.22854] 9 Levkovitz Y, Tedeschini E, Papakostas GI. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials The Journal of clinical psychiatry 2011; 72(4): 509-514 10 Schumer MC, Bartley CA, Bloch MH. Systematic Review of Pharmacological and Behavioral Treatments for Skin Picking Disorder Journal of clinical psychopharmacology 2016; 36(2): 147–152 [PMCID: 26872117 Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1097/jcp.0000000000000462] 11 Selles RR, McGuire JF, Small BJ, Storch EA. A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder General hospital psychiatry 2016; 41: 29–37 [PMCID: 27143352 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1016/j.genhosppsych.2016.04.001] 12 Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ. Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials The international journal of neuropsychopharmacology 2015; 19(2) [PMCID: 26152228 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1093/ijnp/pyv076] 13 Sugarman MA, Loree AM, Baltes BB, Grekin ER, Kirsch I. The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales PloS one 2014; 9(8): e106337 [PMCID: 25162656 Journal Article Meta-Analysis DOI: 10.1371/journal.pone.0106337] 14 Guina J, Rossetter SR, DeRhodes BJ, Nahhas RW, Welton RS. Benzodiazepines for PTSD: a systematic review and meta-analysis Journal of Psychiatric Practice® 2015; 21(4): 281-303 15 Chen C, Shan W. Pharmacological and non-pharmacological treatments for major depressive disorder in adults: A systematic review and network meta-analysis Psychiatry research 2019; 281: 112595 [PMCID: 31627074 Journal Article Systematic Review DOI: 10.1016/j.psychres.2019.112595]



16 Breilmann J, Furukawa TA, Becker T, Koesters M. Differences in the placebo response in duloxetine and venlafaxine trials Acta psychiatrica Scandinavica 2018; 137(6): 472–480 [PMCID: 29603140 Comparative Study Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1111/acps.12881] 17 Feng G, Han M, Li X, Geng L, Miao Y. Clinical effectiveness of Tui Na for insomnia compared with estazolam: A systematic review and meta-analysis of randomized controlled trials Complementary therapies in medicine 2019; 47: 102186 [PMCID: 31779989 Journal Article Meta-Analysis Systematic Review DOI: 10.1016/j.ctim.2019.08.020] 18 Fu Z, Zhou S, Burger H, Bockting CLH, Williams AD. Psychological interventions for depression in Chinese university students: A systematic review and meta-analysis Journal of affective disorders 2020; 262: 440–450 [PMCID: 31744736 Journal Article Review Research Support, Non-U.S. Gov't DOI: 10.1016/j.jad.2019.11.058] 19 Kuester A, Niemeyer H, Knaevelsrud C. Internet-based interventions for posttraumatic stress: A meta-analysis of randomized controlled trials Clinical psychology review 2016; 43: 1–16 [PMCID: 26655959 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1016/j.cpr.2015.11.004] 20 Lopez PL, Torrente FM, Ciapponi A, Lischinsky AG, Cetkovich-Bakmas M, Rojas JI, Romano M, Manes FF. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults The Cochrane database of systematic reviews 2018; 3: CD010840 [PMCID: 29566425 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1002/14651858.CD010840.pub2] 21 Mizuno Y, McCutcheon RA, Brugger SP, Howes OD. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2020; 45(4): 622–631 [PMCID: 31766049 Journal Article Research Support, Non-U.S. Gov't DOI: 10.1038/s41386-019-0577-3] 22 Okhuijsen-Pfeifer C, Huijsman EAH, Hasan A, Sommer IEC, Leucht S, Kahn RS, Luykx JJ. Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis Acta psychiatrica Scandinavica 2018; 138(4): 281–288 [PMCID: 30218445 Journal Article Meta-Analysis Systematic Review DOI: 10.1111/acps.12954] 23 Philipp R, Kriston L, Lanio J, Kühne F, Härter M, Moritz S, Meister R. Effectiveness of metacognitive interventions for mental disorders in adults-A systematic review and meta-analysis (METACOG) Clinical psychology & psychotherapy 2019; 26(2): 227–240 [PMCID: 30456821 Journal Article Meta-Analysis Systematic Review DOI: 10.1002/cpp.2345] 24 Romijn G, Batelaan N, Kok R, Koning J, van Balkom A, Titov N, Riper H. Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Open Community Versus Clinical Service Recruitment: Meta-Analysis Journal of medical Internet research 2019; 21(4): e11706 [PMCID: 30994462 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review DOI: 10.2196/11706] 25 Samara MT, Cao H, Helfer B, Davis JM, Leucht S. Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2014; 24(7): 1046–1055 [PMCID: 24766970 Comparative Study Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1016/j.euroneuro.2014.03.012] 26 Swift JK, Greenberg RP, Tompkins KA, Parkin SR. Treatment refusal and premature termination in psychotherapy, pharmacotherapy, and their combination: A meta-analysis of head-to-head comparisons Psychotherapy (Chicago, Ill) 2017; 54(1): 47–57 [PMCID: 28263651 Comparative Study Journal Article Meta-Analysis Review Systematic Review Webcast DOI: 10.1037/pst0000104] 27 van der Zweerde T, Bisdounis L, Kyle SD, Lancee J, van Straten A. Cognitive behavioral therapy for insomnia: A meta-analysis of long-term effects in controlled studies Sleep medicine reviews 2019; 48: 101208 [PMCID: 31491656 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review DOI: 10.1016/j.smrv.2019.08.002]



28 Watts SE, Turnell A, Kladnitski N, Newby JM, Andrews G. Treatment-as-usual (TAU) is anything but usual: a meta-analysis of CBT versus TAU for anxiety and depression Journal of affective disorders 2015; 175: 152–167 [PMCID: 25618002 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't DOI: 10.1016/j.jad.2014.12.025] 29 Wechsler TF, Mühlberger A, Kümpers F. Inferiority or Even Superiority of Virtual Reality Exposure Therapy in Phobias?-A Systematic Review and Quantitative Meta-Analysis on Randomized Controlled Trials Specifically Comparing the Efficacy of Virtual Reality Exposure to Gold Standard In Vivo Exposure in Agoraphobia, Specific Phobia and Social Phobia Frontiers in psychology 2019; 10: 1758 30 Whiston A, Bockting CLH, Semkovska M. Towards personalising treatment: a systematic review and meta-analysis of face-to-face efficacy moderators of cognitive-behavioral therapy and interpersonal psychotherapy for major depressive disorder Psychological medicine 2019; 49(16): 2657–2668 [PMCID: 31615583 Comparative Study Journal Article Meta-Analysis Systematic Review DOI: 10.1017/s0033291719002812] 31 Bahji A, Vazquez GH, Zarate CA, Jr. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis J Affect Disord 2021; 278: 542-555 [PMID: 33022440 PMCID: PMC7704936 DOI: 10.1016/j.jad.2020.09.071] 32 Benz F, Knoop T, Ballesio A, Bacaro V, Johann AF, Rucker G, Feige B, Riemann D, Baglioni C. The efficacy of cognitive and behavior therapies for insomnia on daytime symptoms: A systematic review and network meta-analysis Clin Psychol Rev 2020; 80: 101873 [PMID: 32777632 DOI: 10.1016/j.cpr.2020.101873] 33 Bourbeau K, Moriarty T, Ayanniyi A, Zuhl M. The Combined Effect of Exercise and Behavioral Therapy for Depression and Anxiety: Systematic Review and Meta-Analysis Behav Sci (Basel) 2020; 10(7) [PMID: 32674359 PMCID: PMC7407099 DOI: 10.3390/bs10070116] 34 Chang CH, Lin CH, Liu CY, Chen SJ, Lane HY. Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials J Psychopharmacol 2020; 34(5): 495-505 [PMID: 32122256 DOI: 10.1177/0269881120908016] 35 Gerger H, Werner CP, Gaab J, Cuijpers P. Comparative efficacy and acceptability of expressive writing treatments compared with psychotherapy, other writing treatments, and waiting list control for adult trauma survivors: a systematic review and network meta-analysis Psychol Med 2021: 1-13 [PMID: 33634766 DOI: 10.1017/S0033291721000143] 36 Hilbert A, Petroff D, Herpertz S, Pietrowsky R, Tuschen-Caffier B, Vocks S, Schmidt R. Meta-analysis on the long-term effectiveness of psychological and medical treatments for binge-eating disorder Int J Eat Disord 2020; 53(9): 1353-1376 [PMID: 32583527 DOI: 10.1002/eat.23297] 37 Kishi T, Sakuma K, Okuya M, Matsuda Y, Esumi S, Hashimoto Y, Hatano M, Miyake N, Miura I, Mishima K, Iwata N. Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized, placebo-controlled trials Bipolar Disord 2021 [PMID: 33561884 DOI: 10.1111/bdi.13053] 38 Turner DT, Reijnders M, van der Gaag M, Karyotaki E, Valmaggia LR, Moritz S, Lecomte T, Turkington D, Penades R, Elkis H, Cather C, Shawyer F, O'Connor K, Li ZJ, de Paiva Barretto EM, Cuijpers P. Efficacy and Moderators of Cognitive Behavioural Therapy for Psychosis Versus Other Psychological Interventions: An Individual-Participant Data Meta-Analysis Front Psychiatry 2020; 11: 402 [PMID: 32431633 PMCID: PMC7214739 DOI: 10.3389/fpsyt.2020.00402] 39 Zheng X, He Y, Yin F, Liu H, Li Y, Zheng Q, Li L. Pharmacological interventions for the treatment of insomnia: quantitative comparison of drug efficacy Sleep Med 2020; 72: 41-49 [PMID: 32544795 DOI: 10.1016/j.sleep.2020.03.022] 40 Chiang K-J, Tsai J-C, Liu D, Lin C-H, Chiu H-L, Chou K-R. Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials PloS one 2017; 12(5): e0176849 [PMCID: 28472082 Journal Article Meta-Analysis Systematic Review DOI: 10.1371/journal.pone.0176849] 41 Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis JAMA psychiatry 2017; 74(4): 319–328 [PMCID: 28249086



Journal Article Meta-Analysis Review Systematic Review DOI: 10.1001/jamapsychiatry.2016.4287] 42 Cuijpers P, Sijbrandij M, Koole S, Huibers M, Berking M, Andersson G. Psychological treatment of generalized anxiety disorder: a meta-analysis Clinical psychology review 2014; 34(2): 130-140 43 Cuijpers P, Wit Ld, Kleiboer A, Karyotaki E, Ebert DD. Problem-solving therapy for adult depression: An updated meta-analysis European psychiatry : the journal of the Association of European Psychiatrists 2018; 48: 27–37 [PMCID: 29331596 Journal Article Meta-Analysis DOI: 10.1016/j.eurpsy.2017.11.006] 44 Karatzias T, Murphy P, Cloitre M, Bisson J, Shevlin M, Hyland P, Maercker A, Ben-Ezr M, Coventry P, Mason-Roberts S. Psychological interventions for ICD-11 complex PTSD symptoms: systematic review and meta-analysis Psychological medicine 2019; 49(11): 1761-1775 45 Karyotaki E, Smit Y, de Beurs DP, Henningsen KH, Robays J, Huibers MJ, Weitz E, Cuijpers P. The long‐term efficacy of acute‐phase psychotherapy for depression: A meta‐analysis of randomized trials Depression and anxiety 2016; 33(5): 370-383 46 Keefe JR, McCarthy KS, Dinger U, Zilcha-Mano S, Barber JP. A meta-analytic review of psychodynamic therapies for anxiety disorders Clinical psychology review 2014; 34(4): 309–323 [PMCID: 24786897 Journal Article Meta-Analysis DOI: 10.1016/j.cpr.2014.03.004] 47 Kline AC, Cooper AA, Rytwinksi NK, Feeny NC. Long-term efficacy of psychotherapy for posttraumatic stress disorder: A meta-analysis of randomized controlled trials Clinical psychology review 2018; 59: 30–40 [PMCID: 29169664 Journal Article Meta-Analysis Research Support, N.I.H., Extramural Review DOI: 10.1016/j.cpr.2017.10.009] 48 Knouse LE, Teller J, Brooks MA. Meta-analysis of cognitive-behavioral treatments for adult ADHD Journal of consulting and clinical psychology 2017; 85(7): 737–750 [PMCID: 28504540 Journal Article Meta-Analysis DOI: 10.1037/ccp0000216] 49 Lewis C, Roberts NP, Simon N, Bethell A, Bisson JI. Internet-delivered cognitive behavioural therapy for post-traumatic stress disorder: systematic review and meta-analysis Acta psychiatrica Scandinavica 2019; 140(6): 508–521 [PMCID: 31359407 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1111/acps.13079] 50 Murray SB, Quintana DS, Loeb KL, Griffiths S, Le Grange D. Treatment outcomes for anorexia nervosa: a systematic review and meta-analysis of randomized-controlled trials - CORRIGENDUM Psychological medicine 2019; 49(4): 701–704 [PMCID: 30430952 Journal Article Published Erratum DOI: 10.1017/s0033291718003185] 51 Roberts NP, Kitchiner NJ, Kenardy J, Robertson L, Lewis C, Bisson JI. Multiple session early psychological interventions for the prevention of post-traumatic stress disorder The Cochrane database of systematic reviews 2019; 8: CD006869 [PMCID: 31425615 Journal Article Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1002/14651858.CD006869.pub3] 52 Sijbrandij M, Kleiboer A, Bisson JI, Barbui C, Cuijpers P. Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis The Lancet Psychiatry 2015; 2(5): 413–421 [PMCID: PII: S2215036614001217 DOI: 10.1016/s2215-0366(14)00121-7] 53 Strauss C, Cavanagh K, Oliver A, Pettman D. Mindfulness-based interventions for people diagnosed with a current episode of an anxiety or depressive disorder: a meta-analysis of randomised controlled trials PloS one 2014; 9(4): e96110 [PMCID: 24763812 Journal Article Meta-Analysis DOI: 10.1371/journal.pone.0096110] 54 van der Gaag M, Valmaggia LR, Smit F. The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis Schizophrenia research 2014; 156(1): 30–37 [PMCID: 24731619 Journal Article Meta-Analysis DOI: 10.1016/j.schres.2014.03.016] 55 Velthorst E, Koeter M, van der Gaag M, Nieman DH, Fett A-KJ, Smit F, Staring ABP, Meijer C, Haan Ld. Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regression Psychological medicine 2015; 45(3): 453–465 [PMCID: 24993642



Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review DOI: 10.1017/s0033291714001147] 56 Deng W, Hu D, Xu S, Liu X, Zhao J, Chen Q, Liu J, Zhang Z, Jiang W, Ma L, Hong X, Cheng S, Liu B, Li X. The efficacy of virtual reality exposure therapy for PTSD symptoms: A systematic review and meta-analysis Journal of affective disorders 2019; 257: 698–709 [PMCID: 31382122 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1016/j.jad.2019.07.086] 57 Wright JH, Owen JJ, Richards D, Eells TD, Richardson T, Brown GK, Barrett M, Rasku MA, Polser G, Thase ME. Computer-assisted cognitive-behavior therapy for depression: a systematic review and meta-analysis The Journal of clinical psychiatry 2019; 80(2): 0-0 58 Zhang Z, Zhang L, Zhang G, Jin J, Zheng Z. The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis BMC psychiatry 2018; 18(1): 50 [PMCID: 29475431 Journal Article Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1186/s12888-018-1610-5] 59 Brown E, Shrestha M, Gray R. The safety and efficacy of acceptance and commitment therapy against psychotic symptomatology: a systematic review and meta-analysis Braz J Psychiatry 2020 [PMID: 32756808 DOI: 10.1590/1516-4446-2020-0948] 60 Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, Sateia MJ, Troxel WM, Zhou ES, Kazmi U, Heald JL, Martin JL. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment J Clin Sleep Med 2021; 17(2): 263-298 [PMID: 33164741 PMCID: PMC7853211 DOI: 10.5664/jcsm.8988] 61 Farhat LC, Olfson E, Nasir M, Levine JLS, Li F, Miguel EC, Bloch MH. Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta-analysis Depress Anxiety 2020; 37(8): 715-727 [PMID: 32390221 DOI: 10.1002/da.23028] 62 Fisher PL, Cherry MG, Stuart T, Rigby JW, Temple J. People with obsessive-compulsive disorder often remain symptomatic following psychological treatment: A clinical significance analysis of manualised psychological interventions J Affect Disord 2020; 275: 94-108 [PMID: 32658831 DOI: 10.1016/j.jad.2020.06.019] 63 Ghahari S, Mohammadi-Hasel K, Malakouti SK, Roshanpajouh M. Mindfulness-based Cognitive Therapy for Generalised Anxiety Disorder: a Systematic Review and Meta-analysis East Asian Arch Psychiatry 2020; 30(2): 52-56 [PMID: 32611828 DOI: 10.12809/eaap1885] 64 Keefe JR, McMain SF, McCarthy KS, Zilcha-Mano S, Dinger U, Sahin Z, Graham K, Barber JP. A meta-analysis of psychodynamic treatments for borderline and cluster C personality disorders Personality disorders 2020; 11(3): 157-169 [PMID: 31804128 DOI: 10.1037/per0000382] 65 McCartney M, Nevitt S, Lloyd A, Hill R, White R, Duarte R. Mindfulness-based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta-analysis Acta Psychiatr Scand 2021; 143(1): 6-21 [PMID: 33035356 DOI: 10.1111/acps.13242] 66 Wang YY, Yang Y, Rao WW, Zhang SF, Zeng LN, Zheng W, Ng CH, Ungvari GS, Zhang L, Xiang YT. Cognitive behavioural therapy monotherapy for insomnia: A meta-analysis of randomized controlled trials Asian J Psychiatr 2020; 49: 101828 [PMID: 32115395 DOI: 10.1016/j.ajp.2019.10.008] 67 Xuan R, Li X, Qiao Y, Guo Q, Liu X, Deng W, Hu Q, Wang K, Zhang L. Mindfulness-based cognitive therapy for bipolar disorder: A systematic review and meta-analysis Psychiatry Res 2020; 290: 113116 [PMID: 32480120 DOI: 10.1016/j.psychres.2020.113116] 68 Spong AJ, Clare ICH, Galante J, Crawford MJ, Jones PB. Brief psychological interventions for borderline personality disorder. A systematic review and meta-analysis of randomised controlled trials Clin Psychol Rev 2021; 83: 101937 [PMID: 33220550 DOI: 10.1016/j.cpr.2020.101937] 69 Andrews G, Basu A, Cuijpers P, Craske MG, McEvoy P, English CL, Newby JM. Computer therapy for the anxiety and depression disorders is effective, acceptable and practical health care: An updated meta-analysis Journal of anxiety disorders 2018; 55: 70–78 [PMCID: 29422409 Journal Article Meta-Analysis Review DOI: 10.1016/j.janxdis.2018.01.001] 70 Abbott RA, Whear R, Rodgers LR, Bethel A, Coon JT, Kuyken W, Stein K, Dickens C. Effectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular



disease: A systematic review and meta-analysis of randomised controlled trials Journal of psychosomatic research 2014; 76(5): 341-351 71 Aherne D, Fitzgerald A, Aherne C, Fitzgerald N, Slattery M, Whelan N. Evidence for the treatment of moderate depression: a systematic review Irish journal of psychological medicine 2017; 34(3): 197-204 72 Beard JI, Delgadillo J. Early response to psychological therapy as a predictor of depression and anxiety treatment outcomes: A systematic review and meta‐analysis Depression and anxiety 2019; 36(9): 866-878 73 Çakici N, van Beveren NJM, Judge-Hundal G, Koola MM, Sommer IEC. An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis Psychological medicine 2019; 49(14): 2307–2319 [PMCID: 31439071 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review DOI: 10.1017/s0033291719001995] 74 Cho M, Lee TY, Kwak YB, Yoon YB, Kim M, Kwon JS. Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials The Australian and New Zealand journal of psychiatry 2019; 53(8): 742–759 [PMCID: 30864461 Journal Article Meta-Analysis Systematic Review DOI: 10.1177/0004867419835028] 75 De Hert M, Sermon J, Geerts P, Vansteelandt K, Peuskens J, Detraux J. The use of continuous treatment versus placebo or intermittent treatment strategies in stabilized patients with schizophrenia: a systematic review and meta-analysis of randomized controlled trials with first-and second-generation antipsychotics CNS drugs 2015; 29(8): 637-658 76 Duffy A, Heffer N, Goodday SM, Weir A, Patten S, Malhi GS, Cipriani A. Efficacy and tolerability of lithium for the treatment of acute mania in children with bipolar disorder: A systematic review: A report from the ISBD-IGSLi joint task force on lithium treatment Bipolar disorders 2018; 20(7): 583–593 [PMCID: 30221434 Journal Article Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1111/bdi.12690] 77 Furukawa TA, Noma H, Caldwell DM, Honyashiki M, Shinohara K, Imai H, Chen P, Hunot V, Churchill R. Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis Acta psychiatrica Scandinavica 2014; 130(3): 181–192 [PMCID: 24697518 Journal Article Meta-Analysis DOI: 10.1111/acps.12275] 78 Girlanda F, Cipriani A, Agrimi E, Appino MG, Barichello A, Beneduce R, Bighelli I, Bisoffi G, Bisogno A, Bortolaso P, Boso M, Calandra C, Cascone L, Castellazzi M, Corbascio C, Parise VF, Gardellin F, Gennaro D, Hanife B, Lintas C, Lorusso M, Luca A, Luca M, Luchetta C, Lucii C, Maio F, Marsilio A, Mattei C, Moretti D, Nosè M, Occhionero G, Papanti D, Pecile D, Percudani M, Prestia D, Purgato M, Restaino F, Romeo S, Sciarma T, Strizzolo S, Tamborini S, Todarello O, Tozzi F, Ziero S, Zotos S, Barbui C. Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial BMC Research Notes 2014; 7(1): 1–8 [DOI: 10.1186/1756-0500-7-731] 79 Goldstein E, McDonnell C, Atchley R, Dorado K, Bedford C, Brown RL, Zgierska AE. The Impact of Psychological Interventions on Posttraumatic Stress Disorder and Pain Symptoms: A Systematic Review and Meta-Analysis The Clinical journal of pain 2019; 35(8): 703–712 [PMCID: 31145146 Journal Article Research Support, U.S. Gov't, P.H.S. Research Support, Non-U.S. Gov't DOI: 10.1097/ajp.0000000000000730] 80 González-Valero G, Zurita-Ortega F, Ubago-Jiménez JL, Puertas-Molero P. Use of Meditation and Cognitive Behavioral Therapies for the Treatment of Stress, Depression and Anxiety in Students. A Systematic Review and Meta-Analysis International journal of environmental research and public health 2019; 16(22) [PMCID: 31717682 Journal Article Meta-Analysis Systematic Review DOI: 10.3390/ijerph16224394] 81 Huang AX, Delucchi K, Dunn LB, Nelson JC. A systematic review and meta-analysis of psychotherapy for late-life depression The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2015; 23(3): 261–273 [PMCID: 24856580 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1016/j.jagp.2014.04.003]



82 Ijaz S, Davies P, Williams CJ, Kessler D, Lewis G, Wiles N. Psychological therapies for treatment-resistant depression in adults The Cochrane database of systematic reviews 2018; 5: CD010558 [PMCID: 29761488 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD010558.pub2] 83 Jensen CM, Amdisen BL, Jørgensen KJ, Arnfred SMH. Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses Attention deficit and hyperactivity disorders 2016; 8(1): 3–11 [PMCID: 26801998 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1007/s12402-016-0188-3] 84 Kiluk BD, Ray LA, Walthers J, Bernstein M, Tonigan JS, Magill M. Technology-Delivered Cognitive-Behavioral Interventions for Alcohol Use: A Meta-Analysis Alcoholism, clinical and experimental research 2019; 43(11): 2285–2295 [PMCID: 31566787 Journal Article Meta-Analysis Research Support, N.I.H., Extramural Review DOI: 10.1111/acer.14189] 85 Kishi T, Ikuta T, Matsui Y, Inada K, Matsuda Y, Mishima K, Iwata N. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis Psychological medicine 2019; 49(5): 772–779 [PMCID: 29909790 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't DOI: 10.1017/s0033291718001393] 86 Krause M, Huhn M, Schneider-Thoma J, Rothe P, Smith RC, Leucht S. Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2018; 28(12): 1360–1370 [PMCID: 30243680 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1016/j.euroneuro.2018.09.007] 87 Kriston L, Wolff Av, Westphal A, Hölzel LP, Härter M. Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis Depression and anxiety 2014; 31(8): 621–630 [PMCID: 24448972 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/da.22236] 88 Leucht S, Helfer B, Dold M, Kissling W, McGrath J. Carbamazepine for schizophrenia The Cochrane database of systematic reviews 2014 (5): CD001258 [PMCID: 24789267 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD001258.pub3] 89 Leucht S, Helfer B, Dold M, Kissling W, McGrath JJ. Lithium for schizophrenia The Cochrane database of systematic reviews 2015 (10): CD003834 [PMCID: 26509923 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD003834.pub3] 90 Li J-M, Zhang Y, Su W-J, Liu L-L, Gong H, Peng W, Jiang C-L. Cognitive behavioral therapy for treatment-resistant depression: A systematic review and meta-analysis Psychiatry research 2018; 268: 243–250 [PMCID: 30071387 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1016/j.psychres.2018.07.020] 91 Linde K, Rücker G, Sigterman K, Jamil S, Meissner K, Schneider A, Kriston L. Comparative effectiveness of psychological treatments for depressive disorders in primary care: network meta-analysis BMC family practice 2015; 16: 103 [PMCID: 26286590 Comparative Study Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1186/s12875-015-0314-x] 92 Locher C, Kossowsky J, Gaab J, Kirsch I, Bain P, Krummenacher P. Moderation of antidepressant and placebo outcomes by baseline severity in late-life depression: A systematic review and meta-analysis Journal of affective disorders 2015; 181: 50–60 [PMCID: 25917293 Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1016/j.jad.2015.03.062] 93 Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence The Cochrane database of systematic reviews 2014 (2): CD002207 [PMCID: 24500948



Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD002207.pub4] 94 McIntyre RS, Lee Y, Zhou AJ, Rosenblat JD, Peters EM, Lam RW, Kennedy SH, Rong C, Jerrell JM. The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis Journal of clinical psychopharmacology 2017; 37(4): 412–418 [PMCID: 28590365 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1097/jcp.0000000000000723] 95 Miniati M, Callari A, Calugi S, Rucci P, Savino M, Mauri M, Dell'Osso L. Interpersonal psychotherapy for postpartum depression: a systematic review Archives of women's mental health 2014; 17(4): 257–268 [PMCID: 24957781 Journal Article Review Systematic Review DOI: 10.1007/s00737-014-0442-7] 96 Morina N, Malek M, Nickerson A, Bryant RA. Meta-analysis of interventions for posttraumatic stress disorder and depression in adult survivors of mass violence in low- and middle-income countries Depression and anxiety 2017; 34(8): 679–691 [PMCID: 28419625 Journal Article Meta-Analysis Review DOI: 10.1002/da.22618] 97 Orfanos S, Banks C, Priebe S. Are Group Psychotherapeutic Treatments Effective for Patients with Schizophrenia? A Systematic Review and Meta-Analysis Psychotherapy and psychosomatics 2015; 84(4): 241–249 [PMCID: 26022543 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1159/000377705] 98 Ortiz‐Orendain J, Covarrubias‐Castillo SA, Vazquez‐Alvarez AO, Castiello‐de Obeso S, Quiñones GEA, Seegers M, Colunga‐Lozano LE. Modafinil for people with schizophrenia or related disorders Cochrane Database of Systematic Reviews 2019 (12) 99 Pani PP, Trogu E, Pacini M, Maremmani I. Anticonvulsants for alcohol dependence Cochrane Database of Systematic Reviews 2014 (2) 100 Perna G, Caldirola D. Management of Treatment-Resistant Panic Disorder Current treatment options in psychiatry 2017; 4(4): 371–386 [PMCID: 29238651 Journal Article Review Compliance with Ethical StandardsGiampaolo Perna declares that he has no conflict of interest. Daniela Caldirola declares that she has no conflict of interest.This article does not contain any studies with human or animal subjects performed by any of the authors. DOI: 10.1007/s40501-017-0128-7] 101 Pham CH, Fang M, Nager J, Matsushima K, Inaba K, Kuza CM. The role of psychological support interventions in trauma patients on mental health outcomes: A systematic review and meta-analysis The journal of trauma and acute care surgery 2019; 87(2): 463–482 [PMCID: 31145380 Journal Article Meta-Analysis Research Support, N.I.H., Extramural Systematic Review DOI: 10.1097/ta.0000000000002371] 102 Roberts NP, Roberts PA, Jones N, Bisson JI. Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis Clinical psychology review 2015; 38: 25–38 [PMCID: 25792193 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1016/j.cpr.2015.02.007] 103 Roberts NP, Roberts PA, Jones N, Bisson JI. Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder The Cochrane database of systematic reviews 2016; 4: CD010204 [PMCID: 27040448 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1002/14651858.CD010204.pub2] 104 Romanelli RJ, Wu FM, Gamba R, Mojtabai R, Segal JB. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials Depression and anxiety 2014; 31(8): 641–652 [PMCID: 24390912 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1002/da.22232] 105 Ronconi JM, Shiner B, Watts BV. A Meta-Analysis of Depressive Symptom Outcomes in Randomized, Controlled Trials for PTSD The Journal of nervous and mental disease 2015; 203(7): 522–529 [PMCID: 26075838 Comparative Study Journal Article Meta-Analysis Research Support, U.S. Gov't, Non-P.H.S. DOI: 10.1097/nmd.0000000000000322]



106 Sabe M, Kirschner M, Kaiser S. Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials Journal of clinical psychopharmacology 2019; 39(6): 658–664 [PMCID: 31688399 Journal Article Meta-Analysis Systematic Review DOI: 10.1097/jcp.0000000000001124] 107 Ahmed S, Stanciu CN, Kotapati PV, Ahmed R, Bhivandkar S, Khan AM, Afridi A, Qureshi M, Esang M. Effectiveness of Gabapentin in Reducing Cravings and Withdrawal in Alcohol Use Disorder: A Meta-Analytic Review. 2019. 108 Schefft C, Guhn A, Brakemeier E-L, Sterzer P, Köhler S. Efficacy of inpatient psychotherapy for major depressive disorder: a meta-analysis of controlled trials Acta psychiatrica Scandinavica 2019; 139(4): 322–335 [PMCID: 30520019 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't DOI: 10.1111/acps.12995] 109 Schwartze D, Barkowski S, Strauss B, Knaevelsrud C, Rosendahl J. Efficacy of group psychotherapy for posttraumatic stress disorder: Systematic review and meta-analysis of randomized controlled trials Psychotherapy research : journal of the Society for Psychotherapy Research 2019; 29(4): 415–431 [PMCID: 29179647 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1080/10503307.2017.1405168] 110 van Bronswijk S, Moopen N, Beijers L, Ruhe HG, Peeters F. Effectiveness of psychotherapy for treatment-resistant depression: a meta-analysis and meta-regression Psychological medicine 2019; 49(3): 366–379 [PMCID: 30139408 Journal Article Meta-Analysis DOI: 10.1017/s003329171800199x] 111 Wang HR, Woo YS, Ahn HS, Ahn IM, Kim HJ, Bahk W-M. Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials The international journal of neuropsychopharmacology 2015; 18(8) [PMCID: 25770098 Journal Article Meta-Analysis Review DOI: 10.1093/ijnp/pyv023] 112 Welten CCM, Koeter MWJ, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HGM, Denys DAJP. Efficacy of drug treatment for acute mania differs across geographic regions: An individual patient data meta-analysis of placebo-controlled studies Journal of psychopharmacology (Oxford, England) 2015; 29(8): 923–932 [PMCID: 26038109 Journal Article Meta-Analysis DOI: 10.1177/0269881115586938] 113 Yolland CO, Hanratty D, Neill E, Rossell SL, Berk M, Dean OM, Castle DJ, Tan EJ, Phillipou A, Harris AW, Barreiros AR, Hansen A, Siskind D. Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia The Australian and New Zealand journal of psychiatry 2020; 54(5): 453–466 [PMCID: 31826654 Journal Article Research Support, Non-U.S. Gov't DOI: 10.1177/0004867419893439] 114 Zhang A, Borhneimer LA, Weaver A, Franklin C, Hai AH, Guz S, Shen L. Cognitive behavioral therapy for primary care depression and anxiety: a secondary meta-analytic review using robust variance estimation in meta-regression Journal of behavioral medicine 2019; 42(6): 1117–1141 [PMCID: 31004323 Journal Article Meta-Analysis Review DOI: 10.1007/s10865-019-00046-z] 115 Zheng W, Zhu X-M, Zhang Q-E, Cheng G, Cai D-B, He J, Ng CH, Ungvari GS, Peng X-J, Ning Y-P, Xiang Y-T. Adjunctive minocycline for major mental disorders: A systematic review Journal of psychopharmacology (Oxford, England) 2019; 33(10): 1215–1226 [PMCID: 31294649 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1177/0269881119858286] 116 Barkowski S, Schwartze D, Strauss B, Burlingame GM, Rosendahl J. Efficacy of group psychotherapy for anxiety disorders: A systematic review and meta-analysis Psychother Res 2020; 30(8): 965-982 [PMID: 32093586 DOI: 10.1080/10503307.2020.1729440] 117 Clark SD, Van Snellenberg JX, Lawson JM, Abi-Dargham A. Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials Neuropsychopharmacology 2020; 45(11): 1860-1869 [PMID: 32516800 PMCID: PMC7608351 DOI: 10.1038/s41386-020-0730-z]



118 Barnicot K, Michael C, Trione E, Lang S, Saunders T, Sharp M, Crawford MJ. Psychological interventions for acute psychiatric inpatients with schizophrenia-spectrum disorders: A systematic review and meta-analysis Clin Psychol Rev 2020; 82: 101929 [PMID: 33126038 DOI: 10.1016/j.cpr.2020.101929] 119 Burlingame GM, Svien H, Hoppe L, Hunt I, Rosendahl J. "Group therapy for schizophrenia: A meta-analysis": Correction to Burlingame et al. (2020) Psychotherapy (Chic) 2020; 57(4): 597 [PMID: 33301344 DOI: 10.1037/pst0000354] 120 Cheng HY, McGuinness LA, Elbers RG, MacArthur GJ, Taylor A, McAleenan A, Dawson S, Lopez-Lopez JA, Higgins JPT, Cowlishaw S, Lingford-Hughes A, Hickman M, Kessler D. Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis BMJ 2020; 371: m3934 [PMID: 33239318 PMCID: PMC7687021 at www.icmje.org/coi_disclosure.pdf and declare: support from the School for Primary Care Research, National Institute for Health Research for the submitted work; HC, AM, JPTH, and LAM report grants from the National Institute for Health Research (NIHR) School for Primary Care Research during the conduct of the study, LAM reports grants from NIHR doctoral research fellowship during the conduct of the study, ALH reports grants from GSK and Lundbeck and personal fees from Silence Therapeutics during the conduct of the study, JLL reports grants from Economic and Social Research Council outside the submitted work, MH reports personal fess and others from MSD, Gilead, and Abbvie outside the submitted work, ALH reports personal fees from Janssen-Cilag, Pfizer, Sanofi-Aventis, Lundbeck, and others from Opiant and Lightlak (unpaid consultancy) outside the submitted work; ALH led the British Association for Psychopharmacology's guidelines: Evidence based guidelines for the pharmacological management of substance misuse, addiction, and co-morbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 18(3):293-335; and updated in 2012: Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from BAP. J Psychopharmacol 26(7):899-952. The original guidelines received support from Archimedes Pharma, Lundbeck, Pfizer, Schering. ALH was a member of the National Institute for Health and Care Excellence clinical guideline group: Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. A NICE Clinical guideline (CG115) 2011. DOI: 10.1136/bmj.m3934] 121 Janis RA, Burlingame GM, Svien H, Jensen J, Lundgreen R. Group therapy for mood disorders: A meta-analysis Psychother Res 2021; 31(3): 369-385 [PMID: 32930060 DOI: 10.1080/10503307.2020.1817603] 122 Kishi T, Nosaka T, Sakuma K, Okuya M, Iwata N. Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta-analysis of phase 3 trials in Japan Neuropsychopharmacol Rep 2020; 40(3): 314-322 [PMID: 32767739 PMCID: PMC7722667 DOI: 10.1002/npr2.12131] 123 Kishi T, Sakuma K, Okuya M, Matsuda Y, Iwata N. Vortioxetine vs placebo in major depressive disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan Psychiatry Clin Neurosci 2020; 74(5): 330-332 [PMID: 32175646 DOI: 10.1111/pcn.13001] 124 Undurraga J, Vazquez GH, Tondo L, Baldessarini RJ. Antidepressant responses in direct comparisons of melancholic and non-melancholic depression J Psychopharmacol 2020; 34(12): 1335-1341 [PMID: 32900262 DOI: 10.1177/0269881120953983] 125 Wood L, Williams C, Billings J, Johnson S. A systematic review and meta-analysis of cognitive behavioural informed psychological interventions for psychiatric inpatients with psychosis Schizophr Res 2020; 222: 133-144 [PMID: 32586627 DOI: 10.1016/j.schres.2020.03.041] 126 Amoroso T, Workman M. Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: a preliminary meta-analysis and comparison to prolonged exposure therapy Journal of Psychopharmacology 2016; 30(7): 595-600 127 Amos T, Stein DJ, Ipser JC. Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD) Cochrane Database of Systematic Reviews 2014 (7) 128 Baandrup L, Østrup Rasmussen J, Klokker L, Austin S, Bjørnshave T, Fuglsang Bliksted V, Fink-Jensen A, Hedegaard Fohlmann A, Peter Hansen J, Kristine Nielsen M. Treatment of adult patients with schizophrenia and complex mental health needs–a national clinical guideline Nordic journal of psychiatry 2016; 70(3): 231-240



129 Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders Dialogues in clinical neuroscience 2017; 19(2): 93 130 Baune BT, Renger L. Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression–a systematic review Psychiatry research 2014; 219(1): 25-50 131 Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, Farrell M, Degenhardt L. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis The Lancet Psychiatry 2019; 6(12): 995-1010 132 Boccia M, Piccardi L, Guariglia P. How treatment affects the brain: meta-analysis evidence of neural substrates underpinning drug therapy and psychotherapy in major depression Brain imaging and behavior 2016; 10(2): 619-627 133 Caldirola D, Alciati A, Riva A, Perna G. Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years Expert opinion on pharmacotherapy 2018; 19(12): 1357–1368 [PMCID: 30063164 Journal Article Review DOI: 10.1080/14656566.2018.1504921] 134 Catalá-López F, Hutton B, Núñez-Beltrán A, Mayhew AD, Page MJ, Ridao M, Tobías A, Catalá MA, Tabarés-Seisdedos R, Moher D. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials Systematic reviews 2015; 4: 19 [PMCID: 25875125 Comparative Study Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't DOI: 10.1186/s13643-015-0005-7] 135 Chan B, Freeman M, Kondo K, Ayers C, Montgomery J, Paynter R, Kansagara D. Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta‐analysis Addiction 2019; 114(12): 2122-2136 136 Chattopadhyay A, Frey S, Green G. Bifeprunox versus placebo for schizophrenia The Cochrane database of systematic reviews 2016; 10: CD012029 [PMCID: 27732740 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD012029.pub2] 137 Cheng Q, Huang J, Xu L, Li Y, Li H, Shen Y, Zheng Q, Li L. Analysis of time-course, dose-effect, and influencing factors of antidepressants in the treatment of acute adult patients with major depression International Journal of Neuropsychopharmacology 2020; 23(2): 76-87 138 Clarke K, Mayo-Wilson E, Kenny J, Pilling S. Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials Clinical psychology review 2015; 39: 58–70 [PMCID: 25939032 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1016/j.cpr.2015.04.002] 139 Clayton AH, Hwang E, Kornstein SG, Tourian KA, Cheng R-f, Abraham L, Mele L, Boucher M. Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis International clinical psychopharmacology 2015; 30(6): 307–315 [PMCID: 26230270 Journal Article Research Support, Non-U.S. Gov't DOI: 10.1097/yic.0000000000000094] 140 Coghill DR, Banaschewski T, Soutullo C, Cottingham MG, Zuddas A. Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder European child & adolescent psychiatry 2017; 26(11): 1283–1307 [PMCID: 28429134 Journal Article Review Systematic Review DOI: 10.1007/s00787-017-0986-y] 141 Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, Hetrick SE. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents Cochrane database of systematic reviews 2014 (11) 142 Cristea IA, Huibers MJH, David D, Hollon SD, Andersson G, Cuijpers P. The effects of cognitive behavior therapy for adult depression on dysfunctional thinking: A meta-analysis Clinical psychology review 2015; 42: 62–71 [PMCID: 26319193 Journal Article Meta-Analysis Review DOI: 10.1016/j.cpr.2015.08.003]



143 Curran G, Ravindran A. Lithium for bipolar disorder: a review of the recent literature Expert review of neurotherapeutics 2014; 14(9): 1079–1098 [PMCID: 25130062 Journal Article Research Support, Non-U.S. Gov't Review DOI: 10.1586/14737175.2014.947965] 144 Danborg PB, Gøtzsche PC. Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review The International journal of risk & safety in medicine 2019; 30(4): 193–201 [PMCID: 31561392 Journal Article Meta-Analysis Systematic Review DOI: 10.3233/jrs-195063] 145 Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial The Lancet Psychiatry 2019; 6(9): 735-744 146 Duncan C, Weich S, Fenton S-J, Twigg L, Moon G, Madan J, Singh SP, Crepaz-Keay D, Parsons H, Bhui K. A realist approach to the evaluation of complex mental health interventions The British journal of psychiatry : the journal of mental science 2018; 213(2): 451–453 [PMCID: 30027875 Editorial Research Support, Non-U.S. Gov't DOI: 10.1192/bjp.2018.96] 147 Florea I, Danchenko N, Brignone M, Loft H, Rive B, Abetz-Webb L. The effect of vortioxetine on health-related quality of life in patients with major depressive disorder Clinical therapeutics 2015; 37(10): 2309-2323.e2306 [PMCID: 26346592 Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't DOI: 10.1016/j.clinthera.2015.08.008] 148 Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P. Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis The American journal of gastroenterology 2019; 114(1): 21–39 [PMCID: 30177784 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1038/s41395-018-0222-5] 149 Gartlehner G, Wagner G, Matyas N, Titscher V, Greimel J, Lux L, Gaynes BN, Viswanathan M, Patel S, Lohr KN. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews BMJ open 2017; 7(6): e014912 [PMCID: 28615268 Journal Article Review Competing interests: None declared. DOI: 10.1136/bmjopen-2016-014912] 150 Goslar M, Leibetseder M, Muench HM, Hofmann SG, Laireiter A-R. Pharmacological Treatments for Disordered Gambling: A Meta-analysis Journal of gambling studies 2019; 35(2): 415–445 [PMCID: 30570700 Journal Article Meta-Analysis Review DOI: 10.1007/s10899-018-09815-y] 151 Gühne U, Luppa M, König H-H, Hautzinger M, Riedel-Heller S. Ist Psychotherapie bei depressiven Erkrankungen im Alter wirksam? Psychiatrische Praxis 2014; 41(8): 415–423 [PMCID: 25000905 Journal Article Review Systematic Review DOI: 10.1055/s-0034-1370113] 152 Heavens D, Odgers K, Hodgekins J. Cognitive behavioural therapy for anxiety in psychosis: a systematic review and meta-analysis Psychosis 2019; 11(3): 223–237 [DOI: 10.1080/17522439.2019.1618380] 153 Huntley JD, Gould RL, Liu K, Smith M, Howard RJ. Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression BMJ open 2015; 5(4): e005247 [PMCID: 25838501 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1136/bmjopen-2014-005247] 154 Imai H, Tajika A, Chen P, Pompoli A, Guaiana G, Castellazzi M, Bighelli I, Girlanda F, Barbui C, Koesters M, Cipriani A, Furukawa TA. Azapirones versus placebo for panic disorder in adults The Cochrane database of systematic reviews 2014 (9): CD010828 [PMCID: 25268297 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD010828.pub2] 155 Jones JL, Mateus CF, Malcolm RJ, Brady KT, Back SE. Efficacy of ketamine in the treatment of substance use disorders: a systematic review Frontiers in psychiatry 2018; 9: 277 156 Kamenov K, Twomey C, Cabello M, Prina AM, Ayuso-Mateos JL. The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis Psychological medicine 2017; 47(3): 414–425 [PMCID: 27780478



Journal Article Meta-Analysis DOI: 10.1017/s0033291716002774] 157 Kamenov K, Cabello M, Coenen M, Ayuso-Mateos JL. How much do we know about the functional effectiveness of interventions for depression? A systematic review Journal of affective disorders 2015; 188: 89–96 [PMCID: 26344753 Journal Article Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1016/j.jad.2015.08.035] 158 Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies Bipolar disorders 2018 [PMCID: 29441712 Journal Article Review DOI: 10.1111/bdi.12623] 159 Koch K, Mansi K, Haynes E, Adams CE, Sampson S, Furtado VA. Trifluoperazine versus placebo for schizophrenia The Cochrane database of systematic reviews 2014 (1): CD010226 [PMCID: 24414883 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD010226.pub2] 160 Koelen JA, Houtveen JH, Abbass A, Luyten P, Eurelings-Bontekoe EHM, van Broeckhuysen-Kloth SAM, Bühring MEF, Geenen R. Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis The British journal of psychiatry : the journal of mental science 2014; 204(1): 12–19 [PMCID: 24385460 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't DOI: 10.1192/bjp.bp.112.121830] 161 Koeser L, Donisi V, Goldberg DP, McCrone P. Modelling the cost-effectiveness of pharmacotherapy compared with cognitive-behavioural therapy and combination therapy for the treatment of moderate to severe depression in the UK Psychological medicine 2015; 45(14): 3019–3031 [PMCID: 26040631 Journal Article Meta-Analysis Review DOI: 10.1017/s0033291715000951] 162 Kolovos S, van Tulder MW, Cuijpers P, Prigent A, Chevreul K, Riper H, Bosmans JE. The effect of treatment as usual on major depressive disorder: A meta-analysis Journal of affective disorders 2017; 210: 72–81 [PMCID: 28013125 Journal Article Meta-Analysis Review DOI: 10.1016/j.jad.2016.12.013] 163 Krause M, Zhu Y, Huhn M, Schneider-Thoma J, Bighelli I, Nikolakopoulou A, Leucht S. Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis European archives of psychiatry and clinical neuroscience 2018; 268(7): 625-639 164 Lacey M, Jayaram MB. Zuclopenthixol versus placebo for schizophrenia The Cochrane database of systematic reviews 2015 (12): CD010598 [PMCID: 26624987 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD010598.pub2] 165 Leucht S, Helfer B, Hartung B. Perazine for schizophrenia The Cochrane database of systematic reviews 2014 (1): CD002832 [PMCID: 24425538 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD002832.pub3] 166 Liu X-h, Xie X-h, Wang K-y, Cui H. Efficacy and acceptability of atypical antipsychotics for the treatment of post-traumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials Psychiatry research 2014; 219(3): 543–549 [PMCID: 25015709 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't DOI: 10.1016/j.psychres.2014.05.027] 167 Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis JAMA psychiatry 2017; 74(10): 1011–1020 [PMCID: 28854296 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural DOI: 10.1001/jamapsychiatry.2017.2432] 168 Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P. Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials Drug design, development and therapy 2015; 9: 1927–1936 [PMCID: 25897203



Comparative Study Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review DOI: 10.2147/dddt.S79071] 169 Matar HE, Almerie MQ, Sampson SJ. Fluphenazine (oral) versus placebo for schizophrenia The Cochrane database of systematic reviews 2018; 6: CD006352 [PMCID: 29893410 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD006352.pub3] 170 Matthews PRL, Horder J, Pearce M. Selective noradrenaline reuptake inhibitors for schizophrenia The Cochrane database of systematic reviews 2018; 1: CD010219 [PMCID: 29368813 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1002/14651858.CD010219.pub2] 171 McKay D, Tolin DF. Empirically supported psychological treatments and the Research Domain Criteria (RDoC) Journal of affective disorders 2017; 216: 78–88 [PMCID: 27836118 Journal Article Review DOI: 10.1016/j.jad.2016.10.018] 172 Michail M, Birchwood M, Tait L. Protocol for a systematic review and meta-analysis of cognitive-behavioural therapy for social anxiety disorder in psychosis Systematic reviews 2014; 3: 62 [PMCID: 24920188 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't DOI: 10.1186/2046-4053-3-62] 173 Naglich AC, Lin A, Wakhlu S, Adinoff BH. Systematic Review of Combined Pharmacotherapy for the Treatment of Alcohol Use Disorder in Patients Without Comorbid Conditions CNS drugs 2018; 32(1): 13–31 [PMCID: 29273901 Journal Article Research Support, U.S. Gov't, Non-P.H.S. Systematic Review DOI: 10.1007/s40263-017-0484-2] 174 Kalsi N, Altavilla D, Tambelli R, Aceto P, Trentini C, Di Giorgio C, Lai C. Neural Correlates of Outcome of the Psychotherapy Compared to Antidepressant Therapy in Anxiety and Depression Disorders: A Meta-Analysis Frontiers in psychology 2017; 8: 927 [PMCID: 28638359 Journal Article Review DOI: 10.3389/fpsyg.2017.00927] 175 Olagunju AT, Clark SR, Baune BT. Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome The Australian and New Zealand journal of psychiatry 2019; 53(6): 509–527 [PMCID: 30957510 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review DOI: 10.1177/0004867419837358] 176 Ost L-G. The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-analysis Behaviour research and therapy 2014; 61: 105–121 [PMCID: 25193001 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1016/j.brat.2014.07.018] 177 Ostinelli EG, D'Agostino A, Shokraneh F, Salanti G, Furukawa TA. Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis BMJ open 2019; 9(10): e032726 [PMCID: 31601607 Journal Article Competing interests: GS was invited to participate in two scientific meetings on the use of real-world evidence organised by Merck and Biogen. TAF reports personal fees from Meiji, Mitsubishi-Tanabe, MSD and Pfizer and a grant from Mitsubishi-Tanabe, outside the submitted work; TAF has a patent 2018-1 77 688 pending. DOI: 10.1136/bmjopen-2019-032726] 178 Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials PLoS medicine 2015; 12(12): e1001924 [PMCID: 26694529 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1371/journal.pmed.1001924] 179 Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis The Cochrane database of systematic reviews 2016; 4: CD011004 [PMCID: 27071857 Journal Article Meta-Analysis Review Systematic Review DOI: 10.1002/14651858.CD011004.pub2] 180 Pu J, Zhou X, Liu L, Zhang Y, Yang L, Yuan S, Zhang H, Han Y, Zou D, Xie P. Efficacy and acceptability of interpersonal psychotherapy for depression in adolescents: A meta-analysis of randomized controlled trials Psychiatry research 2017; 253: 226–232 [PMCID: 28391140 Journal Article Meta-Analysis DOI: 10.1016/j.psychres.2017.03.023]



181 Punja S, Shamseer L, Hartling L, Urichuk L, Vandermeer B, Nikles J, Vohra S. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents The Cochrane database of systematic reviews 2016; 2: CD009996 [PMCID: 26844979 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD009996.pub2] 182 Reas DL, Grilo CM. Pharmacological treatment of binge eating disorder: update review and synthesis Expert opinion on pharmacotherapy 2015; 16(10): 1463–1478 [PMCID: 26044518 Journal Article Research Support, N.I.H., Extramural Review DOI: 10.1517/14656566.2015.1053465] 183 Roerecke M, Sørensen P, Laramée P, Rahhali N, Rehm J. Clinical relevance of nalmefene versus placebo in alcohol treatment: reduction in mortality risk Journal of psychopharmacology (Oxford, England) 2015; 29(11): 1152–1158 [PMCID: 26349557 Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't DOI: 10.1177/0269881115602487] 184 Rosenblat JD, Kakar R, McIntyre RS. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials The international journal of neuropsychopharmacology 2015; 19(2) [PMCID: 26209859 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1093/ijnp/pyv082] 185 Sampson S, Hosalli P, Furtado VA, Davis JM. Risperidone (depot) for schizophrenia The Cochrane database of systematic reviews 2016; 4: CD004161 [PMCID: 27078222 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD004161.pub2] 186 Schaffer A, Isometsä ET, Tondo L, Moreno DH, Sinyor M, Kessing LV, Turecki G, Weizman A, Azorin J-M, Ha K, Reis C, Cassidy F, Goldstein T, Rihmer Z, Beautrais A, Chou Y-H, Diazgranados N, Levitt AJ, Zarate CA, Yatham L. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder The Australian and New Zealand journal of psychiatry 2015; 49(9): 785–802 [PMCID: 26185269 Journal Article Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1177/0004867415594427] 187 Schneider-Thoma J, Efthimiou O, Huhn M, Krause M, Reichelt L, Röder H, Davis JM, Salanti G, Leucht S. Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials The Lancet Psychiatry 2018; 5(8): 653–663 [PMCID: PII: S2215036618301779 DOI: 10.1016/s2215-0366(18)30177-9] 188 Shahar G, Rogers ML, Shalev H, Joiner TE. Self-criticism, interpersonal conditions, and biosystemic inflammation in suicidal thoughts and behaviors within mood disorders: A bio-cognitive-interpersonal hypothesis Journal of personality 2020; 88(1): 133–145 [PMCID: 30447120 Journal Article Research Support, Non-U.S. Gov't DOI: 10.1111/jopy.12446] 189 Shinohara K, Tajika A, Imai H, Takeshima N, Hayasaka Y, Furukawa TA. Protocol registration and selective outcome reporting in recent psychiatry trials: new antidepressants and cognitive behavioural therapies Acta psychiatrica Scandinavica 2015; 132(6): 489–498 [PMCID: 26367129 Journal Article Meta-Analysis DOI: 10.1111/acps.12502] 190 Solmi M, Veronese N, Zaninotto L, van der Loos MLM, Gao K, Schaffer A, Reis C, Normann C, Anghelescu I-G, Correll CU. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials CNS spectrums 2016; 21(5): 403–418 [PMCID: 27686028 Comparative Study Journal Article Meta-Analysis DOI: 10.1017/s1092852916000523] 191 Spertus J, Horvitz-Lennon M, Normand S-LT. Bayesian Meta-analysis of Multiple Continuous Treatments with Individual Participant-Level Data: An Application to Antipsychotic Drugs Medical decision making : an international journal of the Society for Medical Decision Making 2019; 39(5): 583–592 [PMCID: 31375050 Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't DOI: 10.1177/0272989x19856884]



192 Suttajit S, Srisurapanont M, Maneeton N, Maneeton B. Quetiapine for acute bipolar depression: a systematic review and meta-analysis Drug design, development and therapy 2014; 8: 827–838 [PMCID: 25028535 Journal Article Meta-Analysis Review Systematic Review DOI: 10.2147/dddt.S63779] 193 Takeuchi H, Kantor N, Sanches M, Fervaha G, Agid O, Remington G. One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis The British Journal of Psychiatry 2017; 211(3): 137-143 194 Tanzer T, Shah S, Benson C, Monte Vd, Gore-Jones V, Rossell SL, Dark F, Kisely S, Siskind D, Melo CD. Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis Psychopharmacology 2020; 237(1): 11–19 [PMCID: 31792645 Journal Article Meta-Analysis Systematic Review DOI: 10.1007/s00213-019-05396-9] 195 Thomaes K, Dorrepaal E, Draijer N, Jansma EP, Veltman DJ, van Balkom AJ. Can pharmacological and psychological treatment change brain structure and function in PTSD? A systematic review Journal of psychiatric research 2014; 50: 1–15 [PMCID: 24321592 Journal Article Review Systematic Review DOI: 10.1016/j.jpsychires.2013.11.002] 196 Vittengl JR, Jarrett RB, Weitz E, Hollon SD, Twisk J, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Kennedy SH, Kheirkhah F, Mergl R, Miranda J, Mohr DC, Rush AJ, Segal ZV, Siddique J, Simons AD, Cuijpers P. Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression The American journal of psychiatry 2016; 173(5): 481–490 [PMCID: 26869246 Journal Article Meta-Analysis DOI: 10.1176/appi.ajp.2015.15040492] 197 Wang J, Sampson S. Sulpiride versus placebo for schizophrenia The Cochrane database of systematic reviews 2014 (4): CD007811 [PMCID: 24729184 Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review DOI: 10.1002/14651858.CD007811.pub2] 198 Witt K, Potts J, Hubers A, Grunebaum MF, Murrough JW, Loo C, Cipriani A, Hawton K. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials The Australian and New Zealand journal of psychiatry 2020; 54(1): 29–45 [PMCID: 31729893 Journal Article DOI: 10.1177/0004867419883341] 199 Yap WS, Dolzhenko AV, Jalal Z, Hadi MA, Khan TM. Efficacy and safety of lavender essential oil (Silexan) capsules among patients suffering from anxiety disorders: A network meta-analysis Scientific reports 2019; 9(1): 1-11 200 Zeeck A, Herpertz-Dahlmann B, Friederich H-C, Brockmeyer T, Resmark G, Hagenah U, Ehrlich S, Cuntz U, Zipfel S, Hartmann A. Psychotherapeutic Treatment for Anorexia Nervosa: A Systematic Review and Network Meta-Analysis Frontiers in psychiatry 2018; 9: 158 [PMCID: 29765338 Journal Article Review DOI: 10.3389/fpsyt.2018.00158] 201 Zhang Y, Zhou X, Pu J, Zhang H, Yang L, Liu L, Zhou C, Yuan S, Jiang X, Xie P. Antidepressants for depressive disorder in children and adolescents: a database of randomised controlled trials BMC psychiatry 2018; 18(1): 162 [PMCID: 29855280 Journal Article Research Support, Non-U.S. Gov't Review DOI: 10.1186/s12888-018-1749-0] 202 Zhou X, Cipriani A, Zhang Y, Cuijpers P, Hetrick SE, Weisz JR, Pu J, Giovane CD, Furukawa TA, Barth J, Coghill D, Leucht S, Yang L, Ravindran AV, Xie P. Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis BMJ open 2017; 7(8): e016608 [PMCID: 28801423 Comparative Study Journal Article Meta-Analysis Competing interests: AC reports personal fees from Accord Healthcare as an expert witness for a patent issue about quetiapine extended release. SEH is an editor of the Cochrane Common Mental Disorders Group, an author of the Cochrane systematic review of newer generation antidepressants for depression in children and adolescents. and an author (senior) on the Cochrane review of psychological, pharmacological and their combination for child/adoles depression. DC reports grants and personal fees from Shire; personal fees from Eli Lilly, Janssen Cilag, Novartis, Sandoz, Oxford University Press and grants from European Union FP7, outside of the submitted work. Eli Lilly has provided drugs for a clinical trial led by SL as the principal investigator. AVR reports personal fees from Bristol Myers Squibb, Pfizer, Sunovion; grants from Pfizer, Grand Challenges Canada, Canadian Institute of



Health Research and AstraZeneca, outside of the submitted work. TAF has received lecture fees from Eli Lilly, Janssen, Meiji, MSD, Otsuka, Pfizer and TanabeDMitsubishi and consultancy fees from Sekisui Chemicals and Takeda Science Foundation. He has received royalties from IgakuDShoin and Nihon Bunka KagakuDsha publishers. He has received research support from Mochida and TanabeDMitsubishi. XZ, YZ, PC, JRW, JP, CDG, TAF, JB and LY declare no competing interests. DOI: 10.1136/bmjopen-2017-016608] 203 Bahji A, Ermacora D, Stephenson C, Hawken ER, Vazquez G. Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis Can J Psychiatry 2021; 66(3): 274-288 [PMID: 33174452 DOI: 10.1177/0706743720970857] 204 Coventry PA, Meader N, Melton H, Temple M, Dale H, Wright K, Cloitre M, Karatzias T, Bisson J, Roberts NP, Brown JVE, Barbui C, Churchill R, Lovell K, McMillan D, Gilbody S. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis PLoS Med 2020; 17(8): e1003262 [PMID: 32813696 PMCID: PMC7446790 DOI: 10.1371/journal.pmed.1003262] 205 Cuijpers P, Karyotaki E, Eckshtain D, Ng MY, Corteselli KA, Noma H, Quero S, Weisz JR. Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis JAMA Psychiatry 2020; 77(7): 694-702 [PMID: 32186668 PMCID: PMC7081149 DOI: 10.1001/jamapsychiatry.2020.0164] 206 Delgado A, Velosa J, Zhang J, Dursun SM, Kapczinski F, de Azevedo Cardoso T. Clozapine in bipolar disorder: A systematic review and meta-analysis J Psychiatr Res 2020; 125: 21-27 [PMID: 32182485 DOI: 10.1016/j.jpsychires.2020.02.026] 207 Fortin M, Fortin C, Savard-Kelly P, Guay S, El-Baalbaki G. The effects of psychotherapies for posttraumatic stress disorder on quality of life in the civilian population: A meta-analysis of RCTs Psychol Trauma 2021 [PMID: 33539158 DOI: 10.1037/tra0000992] 208 Galvao-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J. Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants Psychopharmacology (Berl) 2021; 238(2): 341-354 [PMID: 33427944 PMCID: PMC7826317 DOI: 10.1007/s00213-020-05719-1] 209 Jeppesen R, Christensen RHB, Pedersen EMJ, Nordentoft M, Hjorthoj C, Kohler-Forsberg O, Benros ME. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysis Brain Behav Immun 2020; 90: 364-380 [PMID: 32890697 DOI: 10.1016/j.bbi.2020.08.028] 210 Jiang B, He D, Guo Z, Gao Z. Dynamic features of placebo effects addressing persistent insomnia disorder: A meta-analysis of placebo-controlled randomized clinical trials J Sleep Res 2020; 29(4): e12997 [PMID: 32052501 DOI: 10.1111/jsr.12997] 211 Koola MM, Looney SW, Hong H, Pillai A, Hou W. Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement Psychiatry Res 2020; 291: 113285 [PMID: 32763546 DOI: 10.1016/j.psychres.2020.113285] 212 Kopelli E, Samara M, Siargkas A, Goulas A, Papazisis G, Chourdakis M. The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis Psychiatry Res 2020; 291: 113246 [PMID: 32599446 DOI: 10.1016/j.psychres.2020.113246] 213 Mc Glanaghy E, Turner D, Davis GA, Sharpe H, Dougall N, Morris P, Prentice W, Hutton P. A network meta-analysis of psychological interventions for schizophrenia and psychosis: Impact on symptoms Schizophr Res 2021; 228: 447-459 [PMID: 33578368 DOI: 10.1016/j.schres.2020.12.036] 214 Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R, White P. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation Health Technol Assess 2020; 24(46): 1-490 [PMID: 32975190 PMCID: PMC7548871 DOI: 10.3310/hta24460] 215 Maslej MM, Furukawa TA, Cipriani A, Andrews PW, Sanches M, Tomlinson A, Volkmann C, McCutcheon RA, Howes O, Guo X, Mulsant BH. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials JAMA Psychiatry 2021 [PMID: 33595620 PMCID: PMC7890446 DOI: 10.1001/jamapsychiatry.2020.4564] 216 Miklowitz DJ, Efthimiou O, Furukawa TA, Scott J, McLaren R, Geddes JR, Cipriani A. Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis JAMA



Psychiatry 2021; 78(2): 141-150 [PMID: 33052390 PMCID: PMC7557716 DOI: 10.1001/jamapsychiatry.2020.2993] 217 Munkholm K, Winkelbeiner S, Homan P. Individual response to antidepressants for depression in adults-a meta-analysis and simulation study PLoS One 2020; 15(8): e0237950 [PMID: 32853222 PMCID: PMC7451660 DOI: 10.1371/journal.pone.0237950] 218 Nery FG, Li W, DelBello MP, Welge JA. N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials Bipolar Disord 2020 [PMID: 33354859 DOI: 10.1111/bdi.13039] 219 Nourredine M, Jurek L, Auffret M, Iceta S, Grenet G, Kassai B, Cucherat M, Rolland B. Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis CNS Spectr 2020: 1-9 [PMID: 32641176 DOI: 10.1017/S1092852920001613] 220 Peixoto C, Jose Grande A, Gomes Carrilho C, Nardi AE, Cardoso A, Barciela Veras A. Dehydroepiandrosterone for depressive symptoms: A systematic review and meta-analysis of randomized controlled trials J Neurosci Res 2020; 98(12): 2510-2528 [PMID: 32930419 DOI: 10.1002/jnr.24721] 221 Pittas S, Theodoridis X, Haidich AB, Bozikas PV, Papazisis G. The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials Psychopharmacology (Berl) 2021 [PMID: 33641060 DOI: 10.1007/s00213-021-05789-9] 222 Qian H, Shao F, Lenahan C, Shao A, Li Y. Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Frontiers in psychiatry 2020; 11: 603087 [PMID: 33343429 PMCID: PMC7746677 DOI: 10.3389/fpsyt.2020.603087] 223 Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis JAMA Netw Open 2020; 3(6): e208279 [PMID: 32558914 PMCID: PMC7305524 DOI: 10.1001/jamanetworkopen.2020.8279] 224 Rozen N, Aderka IM. Do depressive symptoms affect the outcome of treatments for SAD? A meta analysis of randomized controlled trials Clin Psychol Rev 2020; 80: 101874 [PMID: 32653699 DOI: 10.1016/j.cpr.2020.101874] 225 Siafis S, Deste G, Ceraso A, Mussoni C, Vita A, Hasanagic S, Schneider-Thoma J, Papazisis G, Davis JM, Leucht S. Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis Psychol Med 2020; 50(15): 2622-2633 [PMID: 31625485 DOI: 10.1017/S003329171900285X] 226 Solmi M, Bodini L, Cocozza S, Seeman MV, Vieta E, Dragioti E, Carvalho AF, Fusar-Poli P. Aripiprazole monotherapy as transdiagnostic intervention for the treatment of mental disorders: An umbrella review according to TRANSD criteria Eur Neuropsychopharmacol 2020; 41: 16-27 [PMID: 33077324 DOI: 10.1016/j.euroneuro.2020.09.635] 227 Soneson E, Russo D, Stochl J, Heslin M, Galante J, Knight C, Grey N, Hodgekins J, French P, Fowler D, Lafortune L, Byford S, Jones PB, Perez J. Psychological interventions for people with psychotic experiences: A systematic review and meta-analysis of controlled and uncontrolled effectiveness and economic studies Aust N Z J Psychiatry 2020; 54(7): 673-695 [PMID: 32462893 PMCID: PMC7324911 DOI: 10.1177/0004867420913118] 228 Williams T, McCaul M, Schwarzer G, Cipriani A, Stein DJ, Ipser J. Pharmacological treatments for social anxiety disorder in adults: a systematic review and network meta-analysis Acta Neuropsychiatr 2020; 32(4): 169-176 [PMID: 32039743 DOI: 10.1017/neu.2020.6] 229 Zahediabghari S, Boursiquot P, Links P. Impact of Psychotherapy on Psychosocial Functioning in Borderline Personality Disorder Patients Int J Environ Res Public Health 2020; 17(12) [PMID: 32604913 PMCID: PMC7344452 DOI: 10.3390/ijerph17124610] 230 Zheng W, Xiang YQ, Cai DB, Yang XH, Zhang L, Zheng W, Lu XB, Tong YM, Huang X, Ungvari GS, Sim K, Ning YP, Xiang YT. Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials J Clin Psychopharmacol 2020; 40(4): 386-390 [PMID: 32618683 DOI: 10.1097/JCP.0000000000001245] 231 Antoun Reyad A, Girgis E, Mishriky R. Efficacy and safety of brexpiprazole in acute management of psychiatric disorders: a meta-analysis of randomized controlled trials Int Clin Psychopharmacol 2020; 35(3): 119-128 [PMID: 32141908 DOI: 10.1097/YIC.0000000000000308]



232 Cassioli E, Sensi C, Mannucci E, Ricca V, Rotella F. Pharmacological treatment of acute-phase anorexia nervosa: Evidence from randomized controlled trials J Psychopharmacol 2020; 34(8): 864-873 [PMID: 32448045 DOI: 10.1177/0269881120920453]

Documents

Figure 1 Supplement - Prisma with reasons - with references